Company Overview
AMPHASTAR PHARMACEUTICALS, INC.
AMPHRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
720M
2025 FY
Net Income
98M
2025 FY
Shares Outstanding
47M
2025 FY
EPS
2.1USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1297184
Exchange
Nasdaq
Location
US